REIT - Industrial
Compare Stocks
5 / 10Stock Comparison
SCCE vs TPVG vs HRZN vs LOAN vs GAIN
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
REIT - Mortgage
Asset Management
SCCE vs TPVG vs HRZN vs LOAN vs GAIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Industrial | Asset Management | Asset Management | REIT - Mortgage | Asset Management |
| Market Cap | $1.14B | $234M | $200M | $49M | $663M |
| Revenue (TTM) | $-13M | $97M | $40M | $8M | $90M |
| Net Income (TTM) | $4M | $-12M | $28M | $5M | $130M |
| Gross Margin | — | 83.5% | 18.0% | 99.9% | 68.6% |
| Operating Margin | — | 77.9% | -4.0% | 58.1% | 72.7% |
| Forward P/E | 597.5x | 6.2x | 6.0x | 8.7x | 41.0x |
| Total Debt | $0.00 | $469M | $473M | $23M | $456M |
| Cash & Equiv. | $11M | $20M | $106M | $178K | $14M |
SCCE vs TPVG vs HRZN vs LOAN vs GAIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 22 | May 26 | Return |
|---|---|---|---|
| Sachem Capital Corp… (SCCE) | 100 | 96.8 | -3.2% |
| TriplePoint Venture… (TPVG) | 100 | 33.0 | -67.0% |
| Horizon Technology … (HRZN) | 100 | 32.7 | -67.3% |
| Manhattan Bridge Ca… (LOAN) | 100 | 67.2 | -32.8% |
| Gladstone Investmen… (GAIN) | 100 | 103.3 | +3.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SCCE vs TPVG vs HRZN vs LOAN vs GAIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SCCE has the current edge in this matchup, primarily because of its strength in growth exposure.
- Rev growth 100.0%, EPS growth 104.3%
- 100.0% FFO/revenue growth vs GAIN's -12.9%
- +35.3% vs HRZN's -24.2%
TPVG is the clearest fit if your priority is bank quality.
- NIM 7.4% vs GAIN's 5.5%
HRZN is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 0 yrs, beta 0.77, yield 27.6%
- PEG 0.25 vs TPVG's 6.14
- Lower P/E (6.0x vs 41.0x)
- 27.6% yield, vs GAIN's 10.0%
LOAN is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 0.09, Low D/E 52.1%, current ratio 31.09x
- Beta 0.09, yield 10.7%, current ratio 31.09x
- Beta 0.09 vs TPVG's 0.77, lower leverage
GAIN ranks third and is worth considering specifically for long-term compounding.
- 321.5% 10Y total return vs LOAN's 103.7%
- 72.7% margin vs HRZN's -6.6%
- 10.5% ROA vs TPVG's -1.5%, ROIC 5.3% vs 7.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 100.0% FFO/revenue growth vs GAIN's -12.9% | |
| Value | Lower P/E (6.0x vs 41.0x) | |
| Quality / Margins | 72.7% margin vs HRZN's -6.6% | |
| Stability / Safety | Beta 0.09 vs TPVG's 0.77, lower leverage | |
| Dividends | 27.6% yield, vs GAIN's 10.0% | |
| Momentum (1Y) | +35.3% vs HRZN's -24.2% | |
| Efficiency (ROA) | 10.5% ROA vs TPVG's -1.5%, ROIC 5.3% vs 7.2% |
SCCE vs TPVG vs HRZN vs LOAN vs GAIN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HRZN leads in 2 of 6 categories
LOAN leads 1 • GAIN leads 1 • SCCE leads 0 • TPVG leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — LOAN and GAIN each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TPVG and SCCE operate at a comparable scale, with $97M and -$13M in trailing revenue. GAIN is the more profitable business, keeping 72.7% of every revenue dollar as net income compared to HRZN's -6.6%. On growth, LOAN holds the edge at +14.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | -$13M | $97M | $40M | $8M | $90M |
| EBITDAEarnings before interest/tax | $551,999 | -$22M | $19M | $4M | $58M |
| Net IncomeAfter-tax profit | $4M | -$12M | $28M | $5M | $130M |
| Free Cash FlowCash after capex | $3M | -$59M | $67M | $5M | -$82M |
| Gross MarginGross profit ÷ Revenue | — | +83.5% | +18.0% | +99.9% | +68.6% |
| Operating MarginEBIT ÷ Revenue | — | +77.9% | -4.0% | +58.1% | +72.7% |
| Net MarginNet income ÷ Revenue | — | +50.6% | -6.6% | +70.0% | +72.7% |
| FCF MarginFCF ÷ Revenue | — | -58.7% | +141.5% | +62.6% | +126.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.6% | — | — | +14.6% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -81.9% | -2.3% | -29.6% | -8.3% | +58.1% |
Valuation Metrics
HRZN leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 4.3x trailing earnings, HRZN trades at a 99% valuation discount to SCCE's 597.5x P/E. Adjusting for growth (PEG ratio), HRZN offers better value at 0.18x vs TPVG's 4.67x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.1B | $234M | $200M | $49M | $663M |
| Enterprise ValueMkt cap + debt − cash | $1.1B | $683M | $568M | $71M | $1.1B |
| Trailing P/EPrice ÷ TTM EPS | 597.50x | 4.73x | 4.32x | 8.71x | 9.36x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 6.23x | 6.01x | — | 41.03x |
| PEG RatioP/E ÷ EPS growth rate | — | 4.67x | 0.18x | — | — |
| EV / EBITDAEnterprise value multiple | — | 9.02x | — | 9.00x | 16.91x |
| Price / SalesMarket cap ÷ Revenue | — | 2.41x | 5.01x | 5.04x | 7.38x |
| Price / BookPrice ÷ Book value/share | 6.41x | 0.66x | 0.60x | 1.13x | 1.23x |
| Price / FCFMarket cap ÷ FCF | 455.87x | — | 3.54x | 9.91x | 5.82x |
Profitability & Efficiency
LOAN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GAIN delivers a 21.9% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $-3 for TPVG. LOAN carries lower financial leverage with a 0.52x debt-to-equity ratio, signaling a more conservative balance sheet compared to HRZN's 1.49x. On the Piotroski fundamental quality scale (0–9), LOAN scores 7/9 vs GAIN's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.3% | -3.4% | +9.0% | +12.2% | +21.9% |
| ROA (TTM)Return on assets | +0.8% | -1.5% | +3.6% | +8.1% | +10.5% |
| ROICReturn on invested capital | — | +7.2% | -0.2% | +8.5% | +5.3% |
| ROCEReturn on capital employed | — | +9.4% | -0.2% | +11.3% | +6.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 | 5 | 7 | 4 |
| Debt / EquityFinancial leverage | — | 1.33x | 1.49x | 0.52x | 0.91x |
| Net DebtTotal debt minus cash | -$11M | $449M | $368M | $22M | $441M |
| Cash & Equiv.Liquid assets | $11M | $20M | $106M | $178,012 | $14M |
| Total DebtShort + long-term debt | $0 | $469M | $473M | $23M | $456M |
| Interest CoverageEBIT ÷ Interest expense | — | -1.02x | 0.60x | 3.38x | 1.58x |
Total Returns (Dividends Reinvested)
GAIN leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GAIN five years ago would be worth $17,465 today (with dividends reinvested), compared to $6,859 for HRZN. Over the past 12 months, SCCE leads with a +35.3% total return vs HRZN's -24.2%. The 3-year compound annual growth rate (CAGR) favors GAIN at 16.4% vs HRZN's -10.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +6.2% | -9.6% | -26.3% | -5.4% | +21.8% |
| 1-Year ReturnPast 12 months | +35.3% | +7.4% | -24.2% | -8.6% | +32.3% |
| 3-Year ReturnCumulative with dividends | +48.5% | -5.6% | -27.5% | +17.2% | +57.6% |
| 5-Year ReturnCumulative with dividends | +30.3% | -15.2% | -31.4% | +2.2% | +74.7% |
| 10-Year ReturnCumulative with dividends | +30.3% | +91.2% | +53.2% | +103.7% | +321.5% |
| CAGR (3Y)Annualised 3-year return | +14.1% | -1.9% | -10.2% | +5.4% | +16.4% |
Risk & Volatility
Evenly matched — LOAN and GAIN each lead in 1 of 2 comparable metrics.
Risk & Volatility
LOAN is the less volatile stock with a 0.09 beta — it tends to amplify market swings less than TPVG's 0.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GAIN currently trades 97.2% from its 52-week high vs HRZN's 53.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.67x | 0.77x | 0.77x | 0.09x | 0.51x |
| 52-Week HighHighest price in past year | $24.59 | $7.53 | $8.46 | $5.85 | $17.14 |
| 52-Week LowLowest price in past year | $11.14 | $4.48 | $3.80 | $4.13 | $13.11 |
| % of 52W HighCurrent price vs 52-week peak | +97.2% | +76.6% | +53.7% | +73.0% | +97.2% |
| RSI (14)Momentum oscillator 0–100 | 58.1 | 67.6 | 55.9 | 35.5 | 64.3 |
| Avg Volume (50D)Average daily shares traded | 5K | 501K | 1.2M | 29K | 370K |
Analyst Outlook
HRZN leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: TPVG as "Hold", HRZN as "Hold", GAIN as "Hold". Consensus price targets imply 55.1% upside for TPVG (target: $9) vs -10.0% for GAIN (target: $15). For income investors, HRZN offers the higher dividend yield at 27.62% vs SCCE's 0.85%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | — | Hold |
| Price TargetConsensus 12-month target | — | $8.95 | $6.50 | — | $15.00 |
| # AnalystsCovering analysts | — | 12 | 22 | — | 7 |
| Dividend YieldAnnual dividend ÷ price | +0.8% | +17.8% | +27.6% | +10.7% | +10.0% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 0 | 0 | 0 |
| Dividend / ShareAnnual DPS | $0.20 | $1.02 | $1.25 | $0.46 | $1.66 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +0.0% | 0.0% |
HRZN leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). LOAN leads in 1 (Profitability & Efficiency). 2 tied.
SCCE vs TPVG vs HRZN vs LOAN vs GAIN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SCCE or TPVG or HRZN or LOAN or GAIN a better buy right now?
For growth investors, Sachem Capital Corp.
6. 00% Note (SCCE) is the stronger pick with 100. 0% revenue growth year-over-year, versus -12. 9% for Gladstone Investment Corporation (GAIN). Horizon Technology Finance Corporation (HRZN) offers the better valuation at 4. 3x trailing P/E (6. 0x forward), making it the more compelling value choice. Analysts rate TriplePoint Venture Growth BDC Corp. (TPVG) a "Hold" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SCCE or TPVG or HRZN or LOAN or GAIN?
On trailing P/E, Horizon Technology Finance Corporation (HRZN) is the cheapest at 4.
3x versus Sachem Capital Corp. 6. 00% Note at 597. 5x. On forward P/E, Horizon Technology Finance Corporation is actually cheaper at 6. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Horizon Technology Finance Corporation wins at 0. 25x versus TriplePoint Venture Growth BDC Corp. 's 6. 14x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SCCE or TPVG or HRZN or LOAN or GAIN?
Over the past 5 years, Gladstone Investment Corporation (GAIN) delivered a total return of +74.
7%, compared to -31. 4% for Horizon Technology Finance Corporation (HRZN). Over 10 years, the gap is even starker: GAIN returned +321. 5% versus SCCE's +30. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SCCE or TPVG or HRZN or LOAN or GAIN?
By beta (market sensitivity over 5 years), Manhattan Bridge Capital, Inc.
(LOAN) is the lower-risk stock at 0. 09β versus TriplePoint Venture Growth BDC Corp. 's 0. 77β — meaning TPVG is approximately 738% more volatile than LOAN relative to the S&P 500. On balance sheet safety, Manhattan Bridge Capital, Inc. (LOAN) carries a lower debt/equity ratio of 52% versus 149% for Horizon Technology Finance Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — SCCE or TPVG or HRZN or LOAN or GAIN?
By revenue growth (latest reported year), Sachem Capital Corp.
6. 00% Note (SCCE) is pulling ahead at 100. 0% versus -12. 9% for Gladstone Investment Corporation (GAIN). On earnings-per-share growth, the picture is similar: Horizon Technology Finance Corporation grew EPS 756. 3% year-over-year, compared to -27. 9% for Gladstone Investment Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SCCE or TPVG or HRZN or LOAN or GAIN?
Gladstone Investment Corporation (GAIN) is the more profitable company, earning 72.
7% net margin versus -6. 6% for Horizon Technology Finance Corporation — meaning it keeps 72. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LOAN leads at 81. 6% versus -4. 0% for HRZN. At the gross margin level — before operating expenses — TPVG leads at 83. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SCCE or TPVG or HRZN or LOAN or GAIN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Horizon Technology Finance Corporation (HRZN) is the more undervalued stock at a PEG of 0. 25x versus TriplePoint Venture Growth BDC Corp. 's 6. 14x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Horizon Technology Finance Corporation (HRZN) trades at 6. 0x forward P/E versus 41. 0x for Gladstone Investment Corporation — 35. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TPVG: 55. 1% to $8. 95.
08Which pays a better dividend — SCCE or TPVG or HRZN or LOAN or GAIN?
All stocks in this comparison pay dividends.
Horizon Technology Finance Corporation (HRZN) offers the highest yield at 27. 6%, versus 0. 8% for Sachem Capital Corp. 6. 00% Note (SCCE).
09Is SCCE or TPVG or HRZN or LOAN or GAIN better for a retirement portfolio?
For long-horizon retirement investors, Manhattan Bridge Capital, Inc.
(LOAN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 09), 10. 7% yield, +103. 7% 10Y return). Both have compounded well over 10 years (LOAN: +103. 7%, HRZN: +53. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SCCE and TPVG and HRZN and LOAN and GAIN?
These companies operate in different sectors (SCCE (Real Estate) and TPVG (Financial Services) and HRZN (Financial Services) and LOAN (Real Estate) and GAIN (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SCCE is a small-cap high-growth stock; TPVG is a small-cap high-growth stock; HRZN is a small-cap high-growth stock; LOAN is a small-cap high-growth stock; GAIN is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Financial Services
- Market Cap > $100B
- Revenue Growth > 8%
- Dividend Yield > 11.0%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.